Event content

CPHI North America 2023

Pharmapack 2023

  • Webinar Enabling Digital Health Solutions with the Connected BD UltraSafe Plus™ Passive Needle Guard

    Sub-optimal adherence and persistence to treatment continue to be significant challenges for both on-market drugs and investigational products in clinical development. This is especially true for self-administered medications for chronic disease patients, hence driving the need for improved treatment intak...
  • Webinar Delivering the Difference: Know-how and Cutting-Edge Technology

    The presentation will focus on pressing over the pain points of Pharma Manufacturing, where we present the ECOSYSTEM of Körber Pharma as a great solution. I plan to address the burning questions - What is an Ecosystem and why is it so important in Pharma Manufacturing? The specific details on exploring ...
  • Webinar Product Packaging Design & Sterilization

    Packaging is an integral part of the design for pharmaceutical products and medical devices. Not only does one need to take into account the look, feel, and protective qualities of the packaging but design must be considered when determining the sterilization technology. Determining the sterilization techn...
  • Webinar Sustainable Pharma Packaging

    We at Körber believe the pharmaceutical industry will ultimately dispense of plastic packaging within a few years. Our Rondo Solutions are pioneering when it comes to sustainability. Today pharmaceutical packaging expects to be innovative, compact, safe, and environmentally friendly. That’s because opin...

CPHI Frankfurt 2022

  • Webinar Design of a New Elastomer Formulation for Lyophilization Applications

    4040/40 elastomer formulation was designed with ‘future in mind’ to meet the ever-increasing performance & quality standards expected of primary drug packaging. The presentation will summarize the extensive Quality by Design (QbD) process that was undertaken to develop this new formulation as well as consi...
  • Video Microbiome Therapeutics Market and its Potential for New Therapies

    The human microbiome enlists all the microorganisms and their related metabolites/products identified in and on the human body. Technological advancement has enabled the assessment of the pleiotropic effects of the human gut microbiome in health and diseases. With the extensive role of microbes in human he...
  • Video DARC: exploratory biomarker for retinal disease

    Novai is commercialising DARC, a combination biomarker consisting of Annexin A5 conjugated to a fluorophore (Dy776). ANX776 binds to stressed/apoptotic retinal cells which are visualisable as white spots using equipment routinely used by opticians, optometrists, and ophthalmologists. The images are then an...
  • Webinar On-Demand Manufacturing for Medicine Supply Chain Resiliency & Patient-Ready Medicine Delivery

    On Demand Pharmaceuticals is creating technology platforms that enable point-of-care medicine manufacturing whether on the battlefield or hospital. By building modular automated systems that can produce raw materials to finished drug product, we are strengthening medicine supply chain resiliency and transf...

Pharmapack Europe 2022

CPHI North America 2022

  • Webinar Biomanufacturing and Moore's Law

    The webinar addresses the need for new modalities, evolution of bio manufacturing of new modalities, and comparison with semiconductor manufacturing. This session was broadcast as part of the CPHI North America show.
  • Webinar ESG Framework: What Investors are Looking For

    As global governments and businesses increasingly make bold claims and commitments to tackle the climate emergency, investors are starting to take note by using the ESG framework to move beyond environmental concerns and focus on a company's impact on all the different ecosystems it operates in. The ris...
  • Webinar Manufacturing of Cell and Gene Therapies – Challenges and Opportunities

    This presentation will focus on: The complexities of bioprocessing and manufacturing of biologics to provide a roadmap for development of effective Efficient and scalable processes and platforms that can be adopted successfully to provide patients wide access to cell and gene therapies. This session...
  • Webinar Panel: Make America Pharma Again — Is Domestic Production here To Stay In a Post-Pandemic World?

    In this webinar is originally broadcast as part of CPHI North America, with speakers Robert Bloder, Chief Business Officer, Ascendia Pharma, Chris Senanayake, CEO & CSO, TCG GreenChem, Inc. and John Pennett, Partner-in-Charge of the National Technology and Life Sciences Group, EisnerAmper. The thread line:...